[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

India Bovine Artificial Insemination Market Size, Share & Trends Analysis Report By Solutions (Semen, Services), By Animal (Cow, Buffalo), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

September 2024 | 200 pages | ID: IF909CF2F969EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 2 Business Days

Immunotoxins Market Growth & Trends

The global immunotoxins market is anticipated to reach USD 243.3 million by 2030 and is anticipated to expand at a CAGR of 8.08% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of cancer and technological advancements are some of the factors anticipated to drive market growth.

Immunotoxins are a class of targeted therapeutics that combine a cytotoxic agent with a targeting moiety, such as an antibody or growth factor. The development of immunotoxins has gained momentum due to their potential effectiveness in treating various cancers and other diseases. Cancer is a growing concern worldwide, with an estimated 20 million new cases and 9.7 million deaths in 2022. Immunotoxins consist of an antibody fragment, or a targeting moiety linked to a toxin, which allows for selective delivery of the toxic agent directly to cancer cells. Moreover, the development and application of immunotoxins have evolved significantly over recent years, leading to various ongoing research initiatives aimed at improving their efficacy, reducing immunogenicity, and expanding their therapeutic applications. Researchers are identifying novel tumor-specific antigens that could serve as targets for new immunotoxin therapies.

The COVID-19 pandemic led to significant disruptions in global supply chains. Manufacturing facilities faced shutdowns or reduced operations due to health regulations and workforce shortages. This situation affected the availability of raw materials and components necessary for producing immunotoxins. Moreover, the pandemic fostered collaboration among pharmaceutical companies, academic institutions, and government entities to accelerate drug development processes, further propelling market growth.

However, one of the primary challenges associated with immunotoxin therapies is the potential for severe side effects. Patients may experience adverse reactions such as nausea, diarrhea, and fever. For instance, certain toxins like Ricin-based immunotoxins have been associated with severe complications such as capillary leak syndrome or hepatotoxicity. Such risks can lead to clinical trial terminations or regulatory hurdles during drug approval processes, further limiting market growth.

Immunotoxins Market Report Highlights
  • Based on product, the Diphtheria Toxin (DT) segment held the largest market share of 43.96% in 2023. DT-based immunotoxins are highly effective in targeting specific cancer cells, making them valuable for treating cancers that are resistant to standard therapies like chemotherapy and radiation. On the other hand, Pseudomonas Exotoxin (PE) is anticipated to grow at a significant CAGR over the forecast period.
  • Based on application, in 2023, therapy development segment is anticipated to dominate the market share for the application segment and is anticipated to grow at the fastest CAGR over the forecast period.
  • Based on end-use, pharmaceutical & biotechnology companies segment dominated the end use segment with the largest share of 46.40% in 2023 and is anticipated to grow at the fastest CAGR over the forecast period. However, on the other hand, academic institutes is anticipated to grow at a significant CAGR over the forecast period.
  • Based on region, North America region dominated the market with a share of 41.41% owing to factors such as strong R&D in biotechnology, medicine, and therapeutics, along with substantial government funding. Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period.
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
  1.3.1. Purchased Database
  1.3.2. GVR’s Internal Database
  1.3.3. Secondary Sources
  1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
  1.7.1. Commodity flow analysis
  1.7.2. Brazil Market: CAGR Calculation
1.8. List of Secondary Sources

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

CHAPTER 3. INDIA BOVINE ARTIFICIAL INSEMINATION (AI) MARKET VARIABLE TRENDS & SCOPE

3.1. Market Lineage Outlook
  3.1.1. Parent Market
  3.1.2. Ancillary Market
3.2. Market Dynamics
  3.2.1. Market Driver Analysis
    3.2.1.1. Ongoing Government Initiatives For Increasing Artificial Insemination Practices In The Country
    3.2.1.2. Rising Government Focus On Boosting Milk Production Of The Country
    3.2.1.3. Emerging Efforts From The Authorities To Structurise The Dairy Sector
    3.2.1.4. Increasing Technological Advancements.
  3.2.2. Market Restraint Analysis
    3.2.2.1. Disorganized Dairy Sector In The Country
    3.2.2.2. Closure Of AI Centers In The Country
    3.2.2.3. Limited Penetration
  3.2.3. Market Opportunity Analysis
  3.2.4. Market Challenge Analysis
3.3. India Bovine Artificial Insemination (AI) Market Analysis Tools
  3.3.1. Industry Analysis - Porter’s
    3.3.1.1. Bargaining power of suppliers
    3.3.1.2. Bargaining power of buyers
    3.3.1.3. Threat of substitution
    3.3.1.4. Threat of new entrants
    3.3.1.5. Competitive rivalry
  3.3.2. PESTEL Analysis
    3.3.2.1. Political & Legal landscape
    3.3.2.2. Economic and Social landscape
    3.3.2.3. Technological landscape
    3.3.2.4. Environmental landscape
  3.3.3. Regulatory Framework
  3.3.4. Estimated Bovine Population, by Key Species, by Key States, 2018-2023
  3.3.5. Key Facts & Figures on Artificial Insemination in India
  3.3.6. Pricing Analysis
  3.3.7. COVID-19 Impact Analysis

CHAPTER 4. INDIA BOVINE ARTIFICIAL INSEMINATION (AI) MARKET: SOLUTION ESTIMATES & TREND ANALYSIS

4.1. Segment Dashboard
4.2. India Bovine Artificial Insemination (AI) Market: Solution Movement Analysis
4.3. India Bovine Artificial Insemination (AI) Market Size & Trend Analysis, by solution, 2018 to 2030 (USD Million)
4.4. Equipment & Consumables
  4.4.1. Equipment & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Semen
  4.5.1. Semen Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.5.2. Normal (Conventional) Semen
    4.5.2.1. Normal (Conventional) Semen Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.5.3. Sexed Semen
    4.5.3.1. Sexed Semen Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Services
  4.6.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 5. INDIA BOVINE ARTIFICIAL INSEMINATION (AI) MARKET: ANIMAL ESTIMATES & TREND ANALYSIS

5.1. Segment Dashboard
5.2. India Bovine Artificial Insemination (AI) Market: Animal Movement Analysis
5.3. India Bovine Artificial Insemination (AI) Market Size & Trend Analysis, by animal, 2018 to 2030 (USD Million)
5.4. Cow
  5.4.1. Cow Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Buffalo
  5.5.1. Buffalo Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 6. INDIA BOVINE ARTIFICIAL INSEMINATION (AI) MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS

6.1. Segment Dashboard
6.2. India Bovine Artificial Insemination (AI) Market: Distribution Channel Movement Analysis
6.3. India Bovine Artificial Insemination (AI) Market Size & Trend Analysis, by distribution channel, 2018 to 2030 (USD Million)
6.4. Government Centers
  6.4.1. Government Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Dairy Cooperatives
  6.5.1. Dairy Cooperatives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Other Agencies
  6.6.1. Other Agencies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 7. INDIA BOVINE ARTIFICIAL INSEMINATION MARKET: COUNTRY ESTIMATES & TREND ANALYSIS, BY SOLUTION, ANIMAL, & DISTRIBUTION CHANNEL

7.1. Regional Dashboard
7.2. India Bovine Artificial Insemination Market Share, By Region, 2023 & 2030 (USD Million)
7.3. Regional Outlook
7.4. Eastern Region
  7.4.1. Eastern Region Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.4.2. West Bengal
    7.4.2.1. West Bengal Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.4.3. Bihar
    7.4.3.1. Bihar Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.4.4. Jharkhand
    7.4.4.1. Jharkhand Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.4.5. Odisha
    7.4.5.1. Odisha Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.4.6. Other States
    7.4.6.1. Other States Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5. Southern Region
  7.5.1. Southern Region Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.5.2. Tamil Nadu
    7.5.2.1. Tamil Nadu Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.5.3. Kerala
    7.5.3.1. Kerala Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.5.4. Telangana
    7.5.4.1. Telangana Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.5.5. Andhra Pradesh
    7.5.5.1. Andhra Pradesh Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.5.6. Karnataka
    7.5.6.1. Karnataka Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6. Western Region
  7.6.1. Western Region Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.6.2. Maharashtra
    7.6.2.1. Maharashtra Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.6.3. Gujarat
    7.6.3.1. Gujarat Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.6.4. Other States
    7.6.4.1. Other States Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.7. Northern Region
  7.7.1. Northern Region Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.7.2. Haryana
    7.7.2.1. Haryana Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030
  7.7.3. Rajasthan
    7.7.3.1. Rajasthan Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.7.4. Punjab
    7.7.4.1. Punjab India Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.7.5. Himachal Pradesh
    7.7.5.1. Himachal Pradesh Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.7.6. Uttar Pradesh
    7.7.6.1. Uttar Pradesh Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.7.7. Uttarakhand
    7.7.7.1. Uttarakhand Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.7.8. Madhya Pradesh
    7.7.8.1. Madhya Pradesh Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.7.9. Chhattisgarh
    7.7.9.1. Chhattisgarh Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.7.10. Other States
    7.7.10.1. Other States Bovine Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)

CHAPTER 8. COMPETITIVE LANDSCAPE

8.1. Market Participant Categorization
8.2. Company Market Position Analysis/ Heap Map Analysis
8.3. Company Profiles
  8.3.1. National Dairy Development Board (NDDB)
    8.3.1.1. Participant’s Overview
    8.3.1.2. Financial Performance
    8.3.1.3. Product Benchmarking
    8.3.1.4. Strategic Initiatives
  8.3.2. Genus plc
    8.3.2.1. Participant’s Overview
    8.3.2.2. Financial Performance
    8.3.2.3. Product Benchmarking
    8.3.2.4. Strategic Initiatives
  8.3.3. Alta Genetics Inc.
    8.3.3.1. Participant’s Overview
    8.3.3.2. Financial Performance
    8.3.3.3. Product Benchmarking
    8.3.3.4. Strategic Initiatives
  8.3.4. Xcell Breeding & Livestock Services Pvt Ltd
    8.3.4.1. Participant’s Overview
    8.3.4.2. Financial Performance
    8.3.4.3. Product Benchmarking
    8.3.4.4. Strategic Initiatives
  8.3.5. Accuvance India
    8.3.5.1. Participant’s Overview
    8.3.5.2. Financial Performance
    8.3.5.3. Product Benchmarking
    8.3.5.4. Strategic Initiatives
  8.3.6. Inguran Sorting Technologies LLP (Stgenetics)
    8.3.6.1. Participant’s Overview
    8.3.6.2. Financial Performance
    8.3.6.3. Product Benchmarking
    8.3.6.4. Strategic Initiatives
  8.3.7. VikingGenetics
    8.3.7.1. Participant’s Overview
    8.3.7.2. Financial Performance
    8.3.7.3. Product Benchmarking
    8.3.7.4. Strategic Initiatives
  8.3.8. Verka (MilkFed)
    8.3.8.1. Participant’s Overview
    8.3.8.2. Financial Performance
    8.3.8.3. Product Benchmarking
    8.3.8.4. Strategic Initiatives
  8.3.9. IMV Technologies
    8.3.9.1. Participant’s Overview
    8.3.9.2. Financial Performance
    8.3.9.3. Product Benchmarking
    8.3.9.4. Strategic Initiatives
  8.3.10. MINITЬB GMBH
    8.3.10.1. Participant’s Overview
    8.3.10.2. Financial Performance
    8.3.10.3. Product Benchmarking
    8.3.10.4. Strategic Initiatives
  8.3.11. Paayas Milk Producer Company Ltd.
    8.3.11.1. Participant’s Overview
    8.3.11.2. Financial Performance
    8.3.11.3. Product Benchmarking
    8.3.11.4. Strategic Initiatives
  8.3.12. Amul Dairy
    8.3.12.1. Participant’s Overview
    8.3.12.2. Financial Performance
    8.3.12.3. Product Benchmarking
    8.3.12.4. Strategic Initiatives
  8.3.13. Maahi Milk Producer Company Ltd.
    8.3.13.1. Participant’s Overview
    8.3.13.2. Financial Performance
    8.3.13.3. Product Benchmarking
    8.3.13.4. Strategic Initiatives
8.4. Strategy Mapping
  8.4.1. Mergers & Acquisitions
  8.4.2. Partnerships & Collaborations
  8.4.3. Expansion
  8.4.4. Product launch
  8.4.5. Product Approval
  8.4.6. Others
8.5. List of Key Companies
  8.5.1. List of Manufacturers
  8.5.2. List of Distributors
  8.5.3. List of Service Providers


More Publications